BEIJING: Rolf Hilgenfeld, a German coronavirus research expert and professor at the Lubeck University, brought two inhibitors developed for severe acute respiratory syndrome-coronavirus (SARS-CoV) to China to test their effects on the 2019 novel coronavirus (2019-nCoV), according to China Media Group (CMG).
Hilgenfeld and his team have been devoted to the research of SARS-CoV inhibitors for many years. The inhibitor uses protease acting on the virus to prevent the protein from cracking, thus preventing the formation of the mature virus.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.